Safety and Preliminary Immunogenicity of Recombinant Hepatitis B (Bio Farma) Vaccine in Adults and Children: A Phase 1 Clinical Trial. Althea Med J. 2023;10(4):242–251. doi:10.15850/amj.v10n4.3279